A couple points to add to an actual discussion. I don't expect a partnership right after the patent. I can see how it might happen but some thing to consider. . If it is Actavis, we are already likely down the path with MIK001.

Its funny there are so many different things going on that it is easy to become a little myopic. . Then you have the HK pharma drug. Who knows what is going on there. . I also think the HITK drug is coming soon.

And the ANDA pendng approval. If you look at companies like HITK, Novel, Epic, this I how you grow your business. And even Lodrane24 which I had written off but now I am not so sure. With or without an ART product, the company is going to be great but things take time. That's not to say the abuse products are not at the forefront. Of course they are but you are just not going to hear much until they have to tell you.

I look at stocks like gambling but much safer. What are the odds Elite gets their ART out there and have a product? 75% although from what I know so far, I think its probably higher then that. Let's make it lower though and say 50%.

Now if they do get a product and we all know the tech is easily repeatable, what does the PPS do? 10x, 20x, 30x? So let's take the low number just for this example. Essentially you have a 50/50 bet that will pay 10x.

Normally a 50/50 bet would pay 2x. So that's massive value. You bet that every day of the week. Now here is where the real value is. What if you lose? You have a company that should get to 1.5-2m per Q by the end of this fiscal year 2014.

That's an 8m number and a 3:1 PE ratio which is low and the company is still growing and adding with another 8 plus products in the hopper. And this does not include 10% of Novel which may very well be worth more then Elite's current market cap by itself. That is a win win. A few overhangs to go but this is the very definition of undervalued